子宫切除术与上皮性卵巢癌相关性临床研究
Correlation of Hysterectomy and Epithelial Ovarian Cancer
摘要: 目的:探讨子宫切除术与散在上皮性卵巢癌(EOC)患病风险的关系;方法:采用以住院患者为基础的病例对照研究,选取青岛大学附属医院2015-01-01~2021-01-01间首次确诊的原发性EOC患者974人作为病例组和985名年龄相匹配的同期住院非卵巢癌患者作为对照组,将2组的一般情况、病例特点和既往子宫切除情况进行比较;结果:2组患者的体重指数、月经初潮年龄、绝经年龄、产次、服用口服避孕药和吸烟等因素比较差异均无统计学意义,均P > 0.05;病例组的子宫切除术(OR = 1.748, 95% CI 1.224~2.498, P = 0.028)发生率均高于对照组,差异有统计学意义;2组患者子宫切除术的手术路径比较差异有统计学意义(χ2 = 9.083, P = 0.011);对于既往是否行子宫切除术,II型EOC的既往子宫切除率明显高于对照组(OR = 1.850, 95% CI 1.286~2.660, P = 0.001),差异有统计学意义;结论:子宫切除术可能增加患EOC的风险,主要增加II型EOC患病风险。开腹子宫切除术比腹腔镜、经阴手术的影响或许更为显著。
Abstract: Objective: To investigate the relationship between hysterectomy and the risk of in sporadic epithe-lial ovarian cancer (EOC). Methods: In a case-control study based on hospitalized patients, 974 pa-tients with primary EOC diagnosed for the first time in the Affiliated Hospital of Qingdao University from 1 January 2015 to 1 January 2021 were selected as the case group and 985 age-matched non-ovarian cancer patients as the control group. The basic conditions and previous hysterectomy of the two groups were compared. Results: There was no significant difference in terms of body mass index, menarche age, menopause age, parity, taking oral contraceptives and smoking between the two groups (P > 0.05). The incidence of hysterectomy (OR = 1.748, 95% CI 1.224~2.498, P = 0.028) in case group were higher than the control group, the difference was statistically significant. There was significant difference in hysterectomy surgery path between the two groups (χ2 = 9.083, P = 0.011). For hysterectomy, there was significant difference between Type II EOC and the control group (OR = 1.850, 95% CI 1.286~2.660, P = 0.001). Conclusion: Hysterectomy may increase the risk of EOC and mainly increase the risk of Type II EOC. The effect of open hysterectomy is more sig-nificant than that of laparoscopy and transvaginal surgery.
文章引用:吕广伟, 于新平, 赵飞, 王黎明. 子宫切除术与上皮性卵巢癌相关性临床研究[J]. 临床医学进展, 2022, 12(5): 4324-4330. https://doi.org/10.12677/ACM.2022.125626

参考文献

[1] Sung, H., Ferlay, J., Siegel, R., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[2] Lutz, A., Willmann, J., Drescher, C., et al. (2011) Early Diagnosis of Ovarian Carcinoma: Is a Solution in Sight? Radiology, 259, 329-345. [Google Scholar] [CrossRef] [PubMed]
[3] Jordan, S., Nagle, C., Coory, M., et al. (2013) Has the Association between Hysterectomy and Ovarian Cancer Changed over Time? A Systematic Review and Meta-Analysis. European Journal of Cancer (Oxford, England: 1990), 49, 3638-3647. [Google Scholar] [CrossRef] [PubMed]
[4] Green, A., Purdie, D., Bain, C., et al. (1997) Tubal Sterilisation, Hysterectomy and Decreased Risk of Ovarian Cancer. Survey of Women’s Health Study Group. International Journal of Cancer, 71, 948-951. [Google Scholar] [CrossRef
[5] Cattanach, J. (1985) Oestrogen Deficiency after Tubal Ligation. The Lancet (London, England), 1, 847-849. [Google Scholar] [CrossRef
[6] Moorman, P., Myers, E., Schildkraut, J., et al. (2011) Effect of Hysterectomy with Ovarian Preservation on Ovarian Function. Obstetrics and Gynecology, 118, 1271-1279. [Google Scholar] [CrossRef
[7] Pike, M.C., Pearce, C.L., Peters, R., et al. (2004) Hormonal Factors and the Risk of Invasive Ovarian Cancer: A Population-Based Case-Control Study. Fertil Steril, 82, 186-195. [Google Scholar] [CrossRef] [PubMed]
[8] Ness, R., Dodge, R., Edwards, R., et al. (2011) Contraception Methods, Beyond Oral Contraceptives and Tubal Ligation, and Risk of Ovarian Cancer. Annals of Epidemiology, 21, 188-196. [Google Scholar] [CrossRef] [PubMed]
[9] Jordan, S., Green, A., Whiteman, D., et al. (2008) Serous Ovarian, Fallopian Tube and Primary Peritoneal Cancers: A Comparative Epidemiological Analysis. International Jour-nal of Cancer, 122, 1598-1603. [Google Scholar] [CrossRef] [PubMed]
[10] Mills, P., Riordan, D. and Cress, R. (2004) Epithelial Ovarian Cancer Risk by Invasiveness and Cell Type in the Central Valley of California. Gynecologic Oncology, 95, 215-225. [Google Scholar] [CrossRef] [PubMed]
[11] Moorman, P., Palmieri, R., Akushevich, L., et al. (2009) Ovarian Cancer Risk Factors in African-American and White Women. American Journal of Epidemiology, 170, 598-606. [Google Scholar] [CrossRef] [PubMed]
[12] Cibula, D., Widschwendter, M., Májek, O., et al. (2011) Tubal Ligation and the Risk of Ovarian Cancer: Review and Meta-Analysis. Human Reproduction Update, 17, 55-67. [Google Scholar] [CrossRef] [PubMed]
[13] Matias-Guiu, X. and Stewart, C. (2018) Endometriosis-Associated Ovarian Neoplasia. Pathology, 50, 190-204. [Google Scholar] [CrossRef] [PubMed]
[14] Harnod, T., Tsai, I., Chen, W., et al. (2019) Hysterectomy and Unilateral Salpingectomy Associate with a Higher Risk of Subsequent Ovarian Cancer: A Population-Based Cohort Study in Taiwan. Medicine, 98, e18058. [Google Scholar] [CrossRef
[15] Ruiz, M., Morales-Ramirez, P., Dziadek, O., et al. (2016) Epithelial Ovarian Cancer and Type of Peritoneal Insult: A Case-Control Study. European Journal of Obstetrics, Gyne-cology, and Reproductive Biology, 205, 170-173. [Google Scholar] [CrossRef] [PubMed]
[16] Carvalho, J. and Carvalho, F. (2008) Is Chlamydia-Infected Tu-bal Fimbria the Origin of Ovarian Cancer? Medical Hypotheses, 71, 690-693. [Google Scholar] [CrossRef] [PubMed]
[17] Ness, R. and Cottreau, C. (1999) Possible Role of Ovarian Epi-thelial Inflammation in Ovarian Cancer. Journal of the National Cancer Institute, 91, 1459-1467. [Google Scholar] [CrossRef] [PubMed]
[18] Quirk, J. and Kupinski, J. (2001) Chronic Infection, Inflammation, and Epithelial Ovarian Cancer. Medical Hypotheses, 57, 426-428. [Google Scholar] [CrossRef] [PubMed]
[19] Idahl, A., Lundin, E., Elgh, F., et al. (2010) Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, Human Papillomavirus, and Polyomavirus Are Not Detectable in Human Tissue with Epithelial Ovarian Cancer, Borderline Tu-mor, or Benign Conditions. American Journal of Obstetrics and Gynecology, 202, 71.e1-6. [Google Scholar] [CrossRef] [PubMed]
[20] Piek, J., Kenemans, P. and Verheijen, R. (2004) Intraperitoneal Se-rous Adenocarcinoma: A Critical Appraisal of Three Hypotheses on Its Cause. American Journal of Obstetrics and Gy-necology, 191, 718-732. [Google Scholar] [CrossRef] [PubMed]
[21] Lonky, N., Mohan, Y., Chiu, V., et al. (2017) Hysterectomy for Benign Conditions: Complications Relative to Surgical Approach and Other Variables That Lead to Post-Operative Re-admission within 90 Days of Surgery. Women’s Health (London, England), 13, 17-26. [Google Scholar] [CrossRef] [PubMed]
[22] Yeh, C., Su, F., Tzeng, C., et al. (2018) Women with Adenomyo-sis Are at Higher Risks of Endometrial and Thyroid Cancers: A Population-Based Historical Cohort Study. PLoS ONE, 13, e0194011. [Google Scholar] [CrossRef] [PubMed]
[23] Kok, V., Tsai, H., Su, C., et al. (2015) The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women with Newly Diagnosed Endometriosis or Adenomyosis: A Population-Based Study. International Journal of Gynecological Cancer: Official Journal of the International Gyneco-logical Cancer Society, 25, 968-976. [Google Scholar] [CrossRef
[24] Bretschneider, C.E., Doll, K.M., Bensen, J.T., et al. (2016) Prevalence of Pelvic Floor Disorders in Women with Suspected Gynecological Malignancy: A Survey-Based Study. In-ternational Urogynecology Journal, 27, 1409-1414. [Google Scholar] [CrossRef] [PubMed]
[25] Tsilidis, K., Allen, N., Key, T., et al. (2011) Menopausal Hor-mone Therapy and Risk of Ovarian Cancer in the European Prospective Investigation into Cancer and Nutrition. Cancer Causes & Control: CCC, 22, 1075-1084. [Google Scholar] [CrossRef] [PubMed]
[26] Peres, L., Alberg, A., Bandera, E., et al. (2017) Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women. American Journal of Epidemiology, 186, 46-53. [Google Scholar] [CrossRef] [PubMed]
[27] Rice, M., Hankinson, S. and Tworoger, S. (2014) Tubal Ligation, Hyster-ectomy, Unilateral Oophorectomy, and Risk of Ovarian Cancer in the Nurses’ Health Studies. Fertility and Sterility, 102, 192-198.e3. [Google Scholar] [CrossRef] [PubMed]
[28] Li, S., O’neill, S., Zhang, Y., et al. (2017) Estrogen Receptor α Is Required for Oviductal Transport of Embryos. FASEB Journal: Official Publication of the Federation of American So-cieties for Experimental Biology, 31, 1595-1607. [Google Scholar] [CrossRef